Male Urinary Incontinence

Global Male Urinary Incontinence Market to Reach US$9.2 Billion by 2030

The global market for Male Urinary Incontinence estimated at US$6.9 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Male Urinary Incontinence Non-Absorbent, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$6.0 Billion by the end of the analysis period. Growth in the Male Urinary Incontinence Absorbents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 8.9% CAGR

The Male Urinary Incontinence market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Male Urinary Incontinence Market – Key Trends & Drivers Summarized

Why Is Male Urinary Incontinence Gaining Importance?

Male urinary incontinence (UI) is a growing health concern, particularly among aging populations and men who have undergone prostate surgery, radiation therapy, or suffer from neurological conditions. It significantly impacts quality of life, leading to physical discomfort, emotional distress, and social embarrassment. The increasing awareness of available treatments and advancements in non-invasive and surgical interventions are driving the market for male urinary incontinence solutions.

The demand for effective and discreet management options, including absorbent pads, external urinary collection devices, pelvic floor therapy, and surgical implants, is increasing as more men seek medical treatment. Innovations in adjustable urinary sphincters, bioengineered implants, and neurostimulation therapies are also contributing to the expanding landscape of urinary incontinence solutions.

How Are Innovations Enhancing the Performance of Male Urinary Incontinence Treatments?

Technology is playing a vital role in improving UI treatment outcomes. Smart wearable pelvic floor therapy devices equipped with biofeedback and AI-driven guidance are helping men regain bladder control without surgery. Additionally, hydraulic sphincter implants and biocompatible slings are improving comfort and long-term efficacy for surgical patients.

The development of non-invasive neuromodulation techniques, which stimulate nerve signals to improve bladder control, is also gaining traction. Custom-fitted urinary incontinence management devices and reusable, eco-friendly absorbent products are further enhancing convenience and sustainability in male UI care.

What Are the Key Market Drivers?

The increasing prevalence of post-prostatectomy incontinence (PPI), obesity-related UI, and diabetes-induced bladder dysfunction is fueling market growth. Aging demographics, particularly in North America and Europe, are leading to higher adoption rates of urinary incontinence solutions, as men over 60 are more likely to experience UI.

Additionally, greater healthcare accessibility and the rise of telemedicine consultations are making it easier for men to seek treatment without stigma. Insurance companies and government healthcare programs are also expanding reimbursement coverage for advanced UI treatments, driving more patients toward medical intervention rather than self-managed solutions.

The growing presence of male-specific wellness clinics and specialized urology treatment centers is further contributing to market expansion. As more men prioritize health and active lifestyles, the demand for discreet, comfortable, and effective urinary incontinence treatments continues to rise.

What Challenges and Future Opportunities Exist?

Challenges include lack of awareness and social stigma preventing men from seeking early medical intervention. Additionally, high costs associated with surgical treatments and limited reimbursement coverage in certain regions hinder adoption. However, emerging AI-powered biofeedback therapy, robotic-assisted incontinence surgeries, and minimally invasive neuromodulation techniques present future growth opportunities. Expansion into developing markets with affordable treatment options could further drive industry growth.

SCOPE OF STUDY:

The report analyzes the Male Urinary Incontinence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Male Urinary Incontinence Non-Absorbent, Male Urinary Incontinence Absorbents); Incontinence (Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Incontinence, Functional Urinary Incontinence, Mixed Urinary Incontinence); Distribution Channel (Offline Stores Distribution Channel, Online Distribution Channels); Usage (Reusable Usage, Disposable Usage); End-Use (Hospitals & Clinics End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• A.M.I. GmbH (Agency for Medical Innovations)
• Attends (Domtar Personal Care)
• Becton, Dickinson and Company (BD)
• Boston Scientific Corporation
• C.R. Bard, Inc. (A subsidiary of BD)
• Caldera Medical
• Coloplast A/S
• Convatec Group plc
• Depend (Kimberly-Clark Corporation)
• First Quality Enterprises, Inc.
• Hollister Incorporated
• Johnson & Johnson
• Medtronic plc
• Men`s Liberty (BioDerm, Inc.)
• NorthShore Care Supply
• Promedon Group
• SCA Hygiene Products AB
• TENA (Essity AB)
• Tranquility (Principle Business Enterprises, Inc.)
• Zephyr Surgical Implants

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.